View Rule

View EO 12866 Meetings Printer-Friendly Version     Download RIN Data in XML

HHS/CMS RIN: 0938-AT91 Publication ID: Spring 2019 
Title: ●International Pricing Index Model For Medicare Part B Drugs (CMS-5528-P) 
Abstract:

This proposed rule considers testing changes to payment for certain separately payable Part B drugs and biologicals.

 
Agency: Department of Health and Human Services(HHS)  Priority: Economically Significant 
RIN Status: First time published in the Unified Agenda Agenda Stage of Rulemaking: Proposed Rule Stage 
Major: Yes  Unfunded Mandates: No 
EO 13771 Designation: Other 
CFR Citation: Not Yet Determined     (To search for a specific CFR, visit the Code of Federal Regulations.)
Legal Authority: Social Security Act, Sec 1115A   
Legal Deadline:  None
Timetable:
Action Date FR Cite
ANPRM  10/30/2018  83 FR 54546   
ANPRM Comment Period End  12/31/2018 
NPRM  08/00/2019 
Regulatory Flexibility Analysis Required: Undetermined  Government Levels Affected: Federal 
Federalism: No 
Included in the Regulatory Plan: No 
International Impacts: This regulatory action will be likely to have international trade and investment effects, or otherwise be of international interest.
RIN Data Printed in the FR: No 
Agency Contact:
Hillary Cavanagh
Health Insurance Specialist
Department of Health and Human Services
Centers for Medicare & Medicaid Services
Center for Medicare and Medicaid Innovation, 7500 Security Boulevard,
Baltimore, MD 21244
Phone:410 786-6574
Email: hillary.cavanagh@cms.hhs.gov